Daniele Veggi, Chelsy C. Chesterman, Laura Santini, Ying Huang, Nicola Pacchiani, Jeannette Sierra, Lynn Chen, Jason Laliberte, Federica Bianchi, Roberta Cozzi, Elisabetta Frigimelica, Domenico Maione, Oretta Finco, Matthew J. Bottomley
Thousands of disease cases and hundreds of deaths occur globally each year due to invasive meningococcal disease. Neisseria meningitidis serogroup B (MenB) is the leading cause of such disease in developed countries. Two vaccines, 4CMenB and MenB-fHbp, that protect against MenB are available and include one or two forms respectively of factor H binding protein (fHbp), a key protective antigen. Studies of circulating meningococci have identified over 1380 different fHbp amino acid sequences, which form three immunologically distinct clusters, termed variants 1, 2, and 3. Neither of the current vaccines contains a variant 2 antigen, which is less well characterized than fHbp variants 1 and 3. We characterized the interaction of fHbp variant 2 with humAb 1B1 using biochemical methods and live meningococcal assays. Further, we determined the crystal structure of the complex at 2.4 Å resolution, clearly revealing the epitope and providing the first detailed report of an antibody with distinct specificity for fHbp variant 2. Extensive mutagenesis and binding studies elucidated key hotspots in the interface. This combination of structural and functional studies provides a molecular explanation for the bactericidal potency and specificity of humAb 1B1 for fHbp variant 2. Our studies, focused on fHbp variant 2, expand the understanding of this previously under characterized group of the vast family of variants of fHbp, a virulence factor present on all meningococci. Moreover, the definition of a protective conformational epitope on fHbp variant 2 may support the design and development of novel variant 2-containing MenB vaccines affording greater breadth of protection.
{"title":"Bactericidal human monoclonal antibody 1B1 shows specificity for meningococcal factor H binding protein variant 2 and displaces human factor H","authors":"Daniele Veggi, Chelsy C. Chesterman, Laura Santini, Ying Huang, Nicola Pacchiani, Jeannette Sierra, Lynn Chen, Jason Laliberte, Federica Bianchi, Roberta Cozzi, Elisabetta Frigimelica, Domenico Maione, Oretta Finco, Matthew J. Bottomley","doi":"10.1096/fba.2023-00077","DOIUrl":"10.1096/fba.2023-00077","url":null,"abstract":"<p>Thousands of disease cases and hundreds of deaths occur globally each year due to invasive meningococcal disease. <i>Neisseria meningitidis</i> serogroup B (MenB) is the leading cause of such disease in developed countries. Two vaccines, 4CMenB and MenB-fHbp, that protect against MenB are available and include one or two forms respectively of factor H binding protein (fHbp), a key protective antigen. Studies of circulating meningococci have identified over 1380 different fHbp amino acid sequences, which form three immunologically distinct clusters, termed variants 1, 2, and 3. Neither of the current vaccines contains a variant 2 antigen, which is less well characterized than fHbp variants 1 and 3. We characterized the interaction of fHbp variant 2 with humAb 1B1 using biochemical methods and live meningococcal assays. Further, we determined the crystal structure of the complex at 2.4 Å resolution, clearly revealing the epitope and providing the first detailed report of an antibody with distinct specificity for fHbp variant 2. Extensive mutagenesis and binding studies elucidated key hotspots in the interface. This combination of structural and functional studies provides a molecular explanation for the bactericidal potency and specificity of humAb 1B1 for fHbp variant 2. Our studies, focused on fHbp variant 2, expand the understanding of this previously under characterized group of the vast family of variants of fHbp, a virulence factor present on all meningococci. Moreover, the definition of a protective conformational epitope on fHbp variant 2 may support the design and development of novel variant 2-containing MenB vaccines affording greater breadth of protection.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":"6 8","pages":"235-248"},"PeriodicalIF":2.5,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11301264/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141901405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Camila J. Cuellar, Thiago F. Amaral, Paula Rodriguez-Villamil, F. Ongaratto, D. Onan Martinez, Rémi Labrecque, João D. de Agostini Losano, Eliab Estrada-Cortés, Jonathan R. Bostrom, Kyra Martins, D. Owen Rae, Jeremy Block, Quinn A. Hoorn, Bradford W. Daigneault, Jonathan Merriam, Michael Lohuis, Serdal Dikmen, João H. J. Bittar, Tatiane S. Maia, Daniel F. Carlson, Sabreena Larson, Tad S. Sonstegard, Peter J. Hansen
Global warming is a major challenge to the sustainable and humane production of food because of the increased risk of livestock to heat stress. Here, the example of the prolactin receptor (PRLR) gene is used to demonstrate how gene editing can increase the resistance of cattle to heat stress by the introduction of mutations conferring thermotolerance. Several cattle populations in South and Central America possess natural mutations in PRLR that result in affected animals having short hair and being thermotolerant. CRISPR/Cas9 technology was used to introduce variants of PRLR in two thermosensitive breeds of cattle – Angus and Jersey. Gene-edited animals exhibited superior ability to regulate vaginal temperature (heifers) and rectal temperature (bulls) compared to animals that were not gene-edited. Moreover, gene-edited animals exhibited superior growth characteristics and had larger scrotal circumference. There was no evidence for deleterious effects of the mutation on carcass characteristics or male reproductive function. These results indicate the potential for reducing heat stress in relevant environments to enhance cattle productivity.
{"title":"Consequences of gene editing of PRLR on thermotolerance, growth, and male reproduction in cattle","authors":"Camila J. Cuellar, Thiago F. Amaral, Paula Rodriguez-Villamil, F. Ongaratto, D. Onan Martinez, Rémi Labrecque, João D. de Agostini Losano, Eliab Estrada-Cortés, Jonathan R. Bostrom, Kyra Martins, D. Owen Rae, Jeremy Block, Quinn A. Hoorn, Bradford W. Daigneault, Jonathan Merriam, Michael Lohuis, Serdal Dikmen, João H. J. Bittar, Tatiane S. Maia, Daniel F. Carlson, Sabreena Larson, Tad S. Sonstegard, Peter J. Hansen","doi":"10.1096/fba.2024-00029","DOIUrl":"10.1096/fba.2024-00029","url":null,"abstract":"<p>Global warming is a major challenge to the sustainable and humane production of food because of the increased risk of livestock to heat stress. Here, the example of the prolactin receptor (<i>PRLR</i>) gene is used to demonstrate how gene editing can increase the resistance of cattle to heat stress by the introduction of mutations conferring thermotolerance. Several cattle populations in South and Central America possess natural mutations in <i>PRLR</i> that result in affected animals having short hair and being thermotolerant. CRISPR/Cas9 technology was used to introduce variants of <i>PRLR</i> in two thermosensitive breeds of cattle – Angus and Jersey. Gene-edited animals exhibited superior ability to regulate vaginal temperature (heifers) and rectal temperature (bulls) compared to animals that were not gene-edited. Moreover, gene-edited animals exhibited superior growth characteristics and had larger scrotal circumference. There was no evidence for deleterious effects of the mutation on carcass characteristics or male reproductive function. These results indicate the potential for reducing heat stress in relevant environments to enhance cattle productivity.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":"6 8","pages":"223-234"},"PeriodicalIF":2.5,"publicationDate":"2024-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11301273/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141901406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Carolina Tecuatl, Bengt Ljungquist, Giorgio A. Ascoli
The tree-like morphology of neurons and glia is a key cellular determinant of circuit connectivity and metabolic function in the nervous system of essentially all animals. To elucidate the contribution of specific cell types to both physiological and pathological brain states, it is important to access detailed neuroanatomy data for quantitative analysis and computational modeling. NeuroMorpho.Org is the largest online collection of freely available digital neural reconstructions and related metadata and is continuously updated with new uploads. Earlier in the project, we released multiple datasets together yearly, but this process caused an average delay of several months in making the data public. Moreover, in the past 5 years, >80% of invited authors agreed to share their data with the community via NeuroMorpho.Org, up from <20% in the first 5 years of the project. In the same period, the average number of reconstructions per publication increased 600%, creating the need for automatic processing to release more reconstructions in less time. The progressive automation of our pipeline enabled the transition to agile releases of individual datasets as soon as they are ready. The overall time from data identification to public sharing decreased by 63.7%; 78% of the datasets are now released in less than 3 months with an average workflow duration below 40 days. Furthermore, the mean processing time per reconstruction dropped from 3 h to 2 min. With these continuous improvements, NeuroMorpho.Org strives to forge a positive culture of open data. Most importantly, the new, original research enabled through reuse of datasets across the world has a multiplicative effect on science discovery, benefiting both authors and users.
{"title":"Accelerating the continuous community sharing of digital neuromorphology data","authors":"Carolina Tecuatl, Bengt Ljungquist, Giorgio A. Ascoli","doi":"10.1096/fba.2024-00048","DOIUrl":"10.1096/fba.2024-00048","url":null,"abstract":"<p>The tree-like morphology of neurons and glia is a key cellular determinant of circuit connectivity and metabolic function in the nervous system of essentially all animals. To elucidate the contribution of specific cell types to both physiological and pathological brain states, it is important to access detailed neuroanatomy data for quantitative analysis and computational modeling. NeuroMorpho.Org is the largest online collection of freely available digital neural reconstructions and related metadata and is continuously updated with new uploads. Earlier in the project, we released multiple datasets together yearly, but this process caused an average delay of several months in making the data public. Moreover, in the past 5 years, >80% of invited authors agreed to share their data with the community via NeuroMorpho.Org, up from <20% in the first 5 years of the project. In the same period, the average number of reconstructions per publication increased 600%, creating the need for automatic processing to release more reconstructions in less time. The progressive automation of our pipeline enabled the transition to agile releases of individual datasets as soon as they are ready. The overall time from data identification to public sharing decreased by 63.7%; 78% of the datasets are now released in less than 3 months with an average workflow duration below 40 days. Furthermore, the mean processing time per reconstruction dropped from 3 h to 2 min. With these continuous improvements, NeuroMorpho.Org strives to forge a positive culture of open data. Most importantly, the new, original research enabled through reuse of datasets across the world has a multiplicative effect on science discovery, benefiting both authors and users.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":"6 7","pages":"207-221"},"PeriodicalIF":2.5,"publicationDate":"2024-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11226999/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141554487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Peace N. Dike, Krishnakant G. Soni, Diana S. Chang, Geoffrey A. Preidis
Bile acids regulate gastrointestinal motility by mechanisms that are poorly understood. Standard isolated tissue bath assays might not recapitulate in vivo physiology if contractile responses to certain bile acids require direct application to the intestinal mucosa. We sought to determine the feasibility of quantifying longitudinal smooth muscle contractile responses to bile acids from intact segments of everted mouse ileum. Ileum from adult female C57BL/6J mice was isolated, gently everted over a notched metal rod, and mounted in tissue baths. Individual bile acids and agonists of bile acid receptors were added to the baths, and longitudinal smooth muscle contractile responses were quantified by isometric force transduction. Ursodeoxycholic acid robustly increased contractile responses in a dose-dependent manner. Deoxycholic acid stimulated contractility at low doses but inhibited contractility at high doses. Chenodeoxycholic acid, glycocholic acid, and lithocholic acid did not alter contractility. The dose-dependent increase in contractility resulting from the application of ursodeoxycholic acid was recapitulated by INT-777, an agonist of the Takeda G protein-coupled receptor 5 (TGR5), and by cevimeline, a muscarinic acetylcholine receptor agonist. Agonists to the nuclear receptors farnesoid X receptor, glucocorticoid receptor, pregnane X receptor, vitamin D receptor, and to the plasma membrane epidermal growth factor receptor did not modify baseline contractile patterns. These results demonstrate that gentle eversion of intact mouse ileum facilitates the quantification of longitudinal smooth muscle contractile responses to individual bile acids. Prokinetic effects of ursodeoxycholic acid and low-dose deoxycholic acid are replicated by agonists to TGR5 and muscarinic acetylcholine receptors.
胆汁酸调节胃肠道运动的机制尚不清楚。如果对某些胆汁酸的收缩反应需要直接作用于肠粘膜,那么标准的离体组织浴试验可能无法再现体内生理学。我们试图确定从完整的小鼠回肠片段量化平滑肌对胆汁酸的纵向收缩反应的可行性。我们分离了成年雌性 C57BL/6J 小鼠的回肠,将其轻轻绞断在有缺口的金属棒上,然后装入组织槽中。在浴槽中加入单个胆汁酸和胆汁酸受体激动剂,并通过等长力传导对纵向平滑肌收缩反应进行量化。熊去氧胆酸能以剂量依赖的方式强力增强收缩反应。脱氧胆酸在低剂量时能刺激收缩力,但在高剂量时会抑制收缩力。去氧胆酸、甘油胆酸和石胆酸不改变收缩力。武田 G 蛋白偶联受体 5(TGR5)激动剂 INT-777 和毒蕈碱乙酰胆碱受体激动剂塞维美林可再现熊去氧胆酸导致的收缩力增加的剂量依赖性。核受体法尼类固醇 X 受体、糖皮质激素受体、孕烷 X 受体、维生素 D 受体以及质膜表皮生长因子受体的激动剂不会改变基线收缩模式。这些结果表明,轻轻倒转完整的小鼠回肠有助于量化纵向平滑肌对单个胆汁酸的收缩反应。TGR5和毒蕈碱乙酰胆碱受体激动剂可复制熊去氧胆酸和小剂量去氧胆酸的促动力效应。
{"title":"Bile acids differentially regulate longitudinal smooth muscle contractility in everted mouse ileum","authors":"Peace N. Dike, Krishnakant G. Soni, Diana S. Chang, Geoffrey A. Preidis","doi":"10.1096/fba.2024-00044","DOIUrl":"10.1096/fba.2024-00044","url":null,"abstract":"<p>Bile acids regulate gastrointestinal motility by mechanisms that are poorly understood. Standard isolated tissue bath assays might not recapitulate in vivo physiology if contractile responses to certain bile acids require direct application to the intestinal mucosa. We sought to determine the feasibility of quantifying longitudinal smooth muscle contractile responses to bile acids from intact segments of everted mouse ileum. Ileum from adult female C57BL/6J mice was isolated, gently everted over a notched metal rod, and mounted in tissue baths. Individual bile acids and agonists of bile acid receptors were added to the baths, and longitudinal smooth muscle contractile responses were quantified by isometric force transduction. Ursodeoxycholic acid robustly increased contractile responses in a dose-dependent manner. Deoxycholic acid stimulated contractility at low doses but inhibited contractility at high doses. Chenodeoxycholic acid, glycocholic acid, and lithocholic acid did not alter contractility. The dose-dependent increase in contractility resulting from the application of ursodeoxycholic acid was recapitulated by INT-777, an agonist of the Takeda G protein-coupled receptor 5 (TGR5), and by cevimeline, a muscarinic acetylcholine receptor agonist. Agonists to the nuclear receptors farnesoid X receptor, glucocorticoid receptor, pregnane X receptor, vitamin D receptor, and to the plasma membrane epidermal growth factor receptor did not modify baseline contractile patterns. These results demonstrate that gentle eversion of intact mouse ileum facilitates the quantification of longitudinal smooth muscle contractile responses to individual bile acids. Prokinetic effects of ursodeoxycholic acid and low-dose deoxycholic acid are replicated by agonists to TGR5 and muscarinic acetylcholine receptors.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":"6 7","pages":"200-206"},"PeriodicalIF":2.5,"publicationDate":"2024-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11226990/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141554488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Eggs not only contain all the molecules necessary to nurture new life but are also rich in nutrients such as high-quality protein. For example, epidemiologic studies have shown that egg intake is positively correlated with cognitive function. Thus, we specifically examined the effect of ovalbumin, a major protein present in egg whites, on cognitive function. First, we found that an orally administered enzymatic digest of ovalbumin improves cognitive function in mice fed a high-fat diet. Then, we narrowed down candidate peptides based on the prediction of peptide production according to enzyme-substrate specificity and comprehensive peptide analysis of the digest. We found that three peptides, namely ILPEY, LYRGGLEP, and ILELP, improve cognitive function after oral administration. We also showed that ILPEY, LYRGGLEP, and ILELP were present in the digest and named them ovomemolins A (OMA), B, and C, respectively. Notably, ovomemolins are the first peptides derived from egg whites that have been shown to improve cognitive function. The cognitive improvement induced by OMA, the most abundant of the peptides in the digest, was inhibited by methyllycaconitine, an antagonist of α7nAChR, which is known to be related to memory. These results suggest that OMA improves cognitive function through the acetylcholine system. After OMA administration, brain-derived neurotrophic factor (BDNF) mRNA expression and the number of 5-bromo-2′-deoxyuridine-positive cells suggested that OMA increases hippocampal BDNF expression and neurogenesis.
{"title":"Ovomemolins: Egg-derived peptides that improved cognitive decline after oral administration in mice","authors":"Takanobu Nakajima, Maiko Shobako, Kentaro Kaneko, Atsushi Kurabayashi, Masaru Sato, Kousaku Ohinata","doi":"10.1096/fba.2023-00149","DOIUrl":"10.1096/fba.2023-00149","url":null,"abstract":"<p>Eggs not only contain all the molecules necessary to nurture new life but are also rich in nutrients such as high-quality protein. For example, epidemiologic studies have shown that egg intake is positively correlated with cognitive function. Thus, we specifically examined the effect of ovalbumin, a major protein present in egg whites, on cognitive function. First, we found that an orally administered enzymatic digest of ovalbumin improves cognitive function in mice fed a high-fat diet. Then, we narrowed down candidate peptides based on the prediction of peptide production according to enzyme-substrate specificity and comprehensive peptide analysis of the digest. We found that three peptides, namely ILPEY, LYRGGLEP, and ILELP, improve cognitive function after oral administration. We also showed that ILPEY, LYRGGLEP, and ILELP were present in the digest and named them ovomemolins A (OMA), B, and C, respectively. Notably, ovomemolins are the first peptides derived from egg whites that have been shown to improve cognitive function. The cognitive improvement induced by OMA, the most abundant of the peptides in the digest, was inhibited by methyllycaconitine, an antagonist of α7nAChR, which is known to be related to memory. These results suggest that OMA improves cognitive function through the acetylcholine system. After OMA administration, brain-derived neurotrophic factor (BDNF) mRNA expression and the number of 5-bromo-2′-deoxyuridine-positive cells suggested that OMA increases hippocampal <i>BDNF</i> expression and neurogenesis.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":"6 7","pages":"177-188"},"PeriodicalIF":2.5,"publicationDate":"2024-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1096/fba.2023-00149","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141361008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Succinate dehydrogenase (SDH) is a key mitochondrial enzyme involved in the tricarboxylic acid cycle, where it facilitates the oxidation of succinate to fumarate, and is coupled to the reduction of ubiquinone in the electron transport chain as Complex II. Previously, we developed a confocal-based quantitative histochemical technique to determine the maximum velocity of the SDH reaction (SDHmax) in single cells and observed that SDHmax corresponds with mitochondrial volume density. In addition, mitochondrial volume and motility varied within different compartments of human airway smooth muscle (hASM) cells. Therefore, we hypothesize that the SDH activity varies relative to the intracellular mitochondrial volume within hASM cells. Using 3D confocal imaging of labeled mitochondria and a concentric shell method for analysis, we quantified mitochondrial volume density, mitochondrial complexity index, and SDHmax relative to the distance from the nuclear membrane. The mitochondria within individual hASM cells were more filamentous in the immediate perinuclear region and were more fragmented in the distal parts of the cell. Within each shell, SDHmax also corresponded to mitochondrial volume density, where both peaked in the perinuclear region and decreased in more distal parts of the cell. Additionally, when normalized to mitochondrial volume, SDHmax was lower in the perinuclear region when compared to the distal parts of the cell. In summary, our results demonstrate that SDHmax measures differences in SDH activity within different cellular compartments. Importantly, our data indicate that mitochondria within individual cells are morphologically heterogeneous, and their distribution varies substantially within different cellular compartments, with distinct functional properties.
{"title":"Heterogeneous distribution of mitochondria and succinate dehydrogenase activity in human airway smooth muscle cells","authors":"Sanjana Mahadev Bhat, Gary C. Sieck","doi":"10.1096/fba.2024-00047","DOIUrl":"https://doi.org/10.1096/fba.2024-00047","url":null,"abstract":"<p>Succinate dehydrogenase (SDH) is a key mitochondrial enzyme involved in the tricarboxylic acid cycle, where it facilitates the oxidation of succinate to fumarate, and is coupled to the reduction of ubiquinone in the electron transport chain as Complex II. Previously, we developed a confocal-based quantitative histochemical technique to determine the maximum velocity of the SDH reaction (SDH<sub>max</sub>) in single cells and observed that SDH<sub>max</sub> corresponds with mitochondrial volume density. In addition, mitochondrial volume and motility varied within different compartments of human airway smooth muscle (hASM) cells. Therefore, we hypothesize that the SDH activity varies relative to the intracellular mitochondrial volume within hASM cells. Using 3D confocal imaging of labeled mitochondria and a concentric shell method for analysis, we quantified mitochondrial volume density, mitochondrial complexity index, and SDH<sub>max</sub> relative to the distance from the nuclear membrane. The mitochondria within individual hASM cells were more filamentous in the immediate perinuclear region and were more fragmented in the distal parts of the cell. Within each shell, SDH<sub>max</sub> also corresponded to mitochondrial volume density, where both peaked in the perinuclear region and decreased in more distal parts of the cell. Additionally, when normalized to mitochondrial volume, SDH<sub>max</sub> was lower in the perinuclear region when compared to the distal parts of the cell. In summary, our results demonstrate that SDH<sub>max</sub> measures differences in SDH activity within different cellular compartments. Importantly, our data indicate that mitochondria within individual cells are morphologically heterogeneous, and their distribution varies substantially within different cellular compartments, with distinct functional properties.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":"6 6","pages":"159-176"},"PeriodicalIF":2.7,"publicationDate":"2024-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1096/fba.2024-00047","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141251512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zamira Gibb, Robert J. Aitken, Alecia R. Sheridan, Brandan Holt, Stephanie Waugh, Aleona Swegen
The in vitro storage of stallion spermatozoa for use in artificial insemination leads to oxidative stress and imbalances in calcium homeostasis that trigger the formation of the mitochondrial permeability transition pore (mPTP), resulting in premature cell death. However, little is understood about the dynamics and the role of mPTP formation in mammalian spermatozoa. Here, we identify an important role for mPTP in stallion sperm Ca2+ homeostasis. We show that stallion spermatozoa do not exhibit “classical” features of mPTP; specifically, they are resistant to cyclosporin A-mediated inhibition of mPTP formation, and they do not require exogenous Ca2+ to form the mPTP. However, chelation of endogenous Ca2+ prevented mPTP formation, indicating a role for intracellular Ca2+ in this process. Furthermore, our findings suggest that this cell type can mobilize intracellular Ca2+ stores to form the mPTP in response to low Ca2+ environments and that under oxidative stress conditions, mPTP formation preceded a measurable increase in intracellular Ca2+, and vice versa. Contrary to previous work that identified mitochondrial membrane potential (MMP) as a proxy for mPTP formation, here we show that a loss of MMP can occur independently of mPTP formation, and thus MMP is not an appropriate proxy for the detection of mPTP formation. In conclusion, the mPTP plays a crucial role in maintaining Ca2+ and reactive oxygen species homeostasis in stallion spermatozoa, serving as an important regulatory mechanism for normal sperm function, thereby contraindicating the in vitro pharmacological inhibition of mPTP formation to enhance sperm longevity.
{"title":"The effects of oxidative stress and intracellular calcium on mitochondrial permeability transition pore formation in equine spermatozoa","authors":"Zamira Gibb, Robert J. Aitken, Alecia R. Sheridan, Brandan Holt, Stephanie Waugh, Aleona Swegen","doi":"10.1096/fba.2023-00051","DOIUrl":"10.1096/fba.2023-00051","url":null,"abstract":"<p>The in vitro storage of stallion spermatozoa for use in artificial insemination leads to oxidative stress and imbalances in calcium homeostasis that trigger the formation of the mitochondrial permeability transition pore (mPTP), resulting in premature cell death. However, little is understood about the dynamics and the role of mPTP formation in mammalian spermatozoa. Here, we identify an important role for mPTP in stallion sperm Ca<sup>2+</sup> homeostasis. We show that stallion spermatozoa do not exhibit “classical” features of mPTP; specifically, they are resistant to cyclosporin A-mediated inhibition of mPTP formation, and they do not require exogenous Ca<sup>2+</sup> to form the mPTP. However, chelation of endogenous Ca<sup>2+</sup> prevented mPTP formation, indicating a role for intracellular Ca<sup>2+</sup> in this process. Furthermore, our findings suggest that this cell type can mobilize intracellular Ca<sup>2+</sup> stores to form the mPTP in response to low Ca<sup>2+</sup> environments and that under oxidative stress conditions, mPTP formation preceded a measurable increase in intracellular Ca<sup>2+</sup>, and vice versa. Contrary to previous work that identified mitochondrial membrane potential (MMP) as a proxy for mPTP formation, here we show that a loss of MMP can occur independently of mPTP formation, and thus MMP is not an appropriate proxy for the detection of mPTP formation. In conclusion, the mPTP plays a crucial role in maintaining Ca<sup>2+</sup> and reactive oxygen species homeostasis in stallion spermatozoa, serving as an important regulatory mechanism for normal sperm function, thereby contraindicating the in vitro pharmacological inhibition of mPTP formation to enhance sperm longevity.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":"6 6","pages":"143-158"},"PeriodicalIF":2.7,"publicationDate":"2024-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1096/fba.2023-00051","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141016951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Autophagy, an intracellular self-degradation process, is governed by a complex interplay of signaling pathways and interactions between proteins and organelles. Its fundamental purpose is to efficiently clear and recycle cellular components that are damaged or redundant. Central to this process are autophagic vesicles, specialized structures that encapsulate targeted cellular elements, playing a pivotal role in autophagy. Despite growing interest in the molecular components of autophagic machinery and their regulatory mechanisms, capturing the detailed ultrastructural dynamics of autophagosome formation continues to present significant challenges. However, recent advancements in microscopy, particularly in electron microscopy, have begun to illuminate the dynamic regulatory processes underpinning autophagy. This review endeavors to provide an exhaustive overview of contemporary research on the ultrastructure of autophagic processes. By synthesizing observations from diverse technological methodologies, this review seeks to deepen our understanding of the genesis of autophagic vesicles, their membrane origins, and the dynamic alterations that transpire during the autophagy process. The aim is to bridge gaps in current knowledge and foster a more comprehensive comprehension of this crucial cellular mechanism.
{"title":"Unraveling the ultrastructure and dynamics of autophagic vesicles: Insights from advanced imaging techniques","authors":"Ting Jiang, Chaoye Ma, Hao Chen","doi":"10.1096/fba.2024-00035","DOIUrl":"10.1096/fba.2024-00035","url":null,"abstract":"<p>Autophagy, an intracellular self-degradation process, is governed by a complex interplay of signaling pathways and interactions between proteins and organelles. Its fundamental purpose is to efficiently clear and recycle cellular components that are damaged or redundant. Central to this process are autophagic vesicles, specialized structures that encapsulate targeted cellular elements, playing a pivotal role in autophagy. Despite growing interest in the molecular components of autophagic machinery and their regulatory mechanisms, capturing the detailed ultrastructural dynamics of autophagosome formation continues to present significant challenges. However, recent advancements in microscopy, particularly in electron microscopy, have begun to illuminate the dynamic regulatory processes underpinning autophagy. This review endeavors to provide an exhaustive overview of contemporary research on the ultrastructure of autophagic processes. By synthesizing observations from diverse technological methodologies, this review seeks to deepen our understanding of the genesis of autophagic vesicles, their membrane origins, and the dynamic alterations that transpire during the autophagy process. The aim is to bridge gaps in current knowledge and foster a more comprehensive comprehension of this crucial cellular mechanism.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":"6 7","pages":"189-199"},"PeriodicalIF":2.5,"publicationDate":"2024-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1096/fba.2024-00035","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141022081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Olufunto O. Badmus, Alexandre A. da Silva, Xuan Li, Lucy C. Taylor, Jennifer R. Greer, Andrew R. Wasson, Karis E. McGowan, Parth R. Patel, David E. Stec
The leading cause of death among patients with metabolic dysfunction-associated steatotic liver disease (MASLD) is cardiovascular disease. A significant percentage of MASLD patients develop heart failure driven by functional and structural alterations in the heart. Previously, we observed cardiac dysfunction in hepatocyte-specific peroxisome proliferator-activated receptor alpha knockout (PparaHepKO), a mouse model that exhibits hepatic steatosis independent of obesity and insulin resistance. The goal of the present study was to determine mechanisms that underlie hepatic steatosis-induced cardiac dysfunction in PparaHepKO mice. Experiments were performed in 30-week-old PparaHepKO and littermate control mice fed regular chow. We observed decreased cardiomyocyte contractility (0.17 ± 0.02 vs. 0.24 ± 0.02 μm, p < 0.05), increased cardiac triglyceride content (0.96 ± 0.13 vs. 0.68 ± 0.06 mM, p < 0.05), collagen type 1 (4.65 ± 0.25 vs. 0.31 ± 0.01 AU, p < 0.001), and collagen type 3 deposition (1.32 ± 0.46 vs. 0.05 ± 0.03 AU, p < 0.05). These changes were associated with increased apoptosis as indicated by terminal deoxynucleotidyl transferase dUTP nick end labeling staining (30.9 ± 4.7 vs. 13.1 ± 0.8%, p < 0.006) and western blots showing increased cleaved caspase-3 (0.27 ± 0.006 vs. 0.08 ± 0.01 AU, p < 0.003) and pro-caspase-3 (5.4 ± 1.5 vs. 0.5 ± 0.3 AU, p < 0.02), B-cell lymphoma protein 2-associated X (0.68 ± 0.07 vs. 0.04 ± 0.04 AU, p < 0.001), and reduced B-cell lymphoma protein 2 (0.29 ± 0.01 vs. 1.47 ± 0.54 AU, p < 0.05). We further observed elevated circulating natriuretic peptides and exercise intolerance in PparaHepKO mice when compared to controls. Our data demonstrated that lipotoxicity, and fibrosis underlie cardiac dysfunction in MASLD.
{"title":"Cardiac lipotoxicity and fibrosis underlie impaired contractility in a mouse model of metabolic dysfunction-associated steatotic liver disease","authors":"Olufunto O. Badmus, Alexandre A. da Silva, Xuan Li, Lucy C. Taylor, Jennifer R. Greer, Andrew R. Wasson, Karis E. McGowan, Parth R. Patel, David E. Stec","doi":"10.1096/fba.2023-00139","DOIUrl":"10.1096/fba.2023-00139","url":null,"abstract":"<p>The leading cause of death among patients with metabolic dysfunction-associated steatotic liver disease (MASLD) is cardiovascular disease. A significant percentage of MASLD patients develop heart failure driven by functional and structural alterations in the heart. Previously, we observed cardiac dysfunction in hepatocyte-specific peroxisome proliferator-activated receptor alpha knockout (<i>Ppara</i><sup>HepKO</sup>), a mouse model that exhibits hepatic steatosis independent of obesity and insulin resistance. The goal of the present study was to determine mechanisms that underlie hepatic steatosis-induced cardiac dysfunction in <i>Ppara</i><sup>HepKO</sup> mice. Experiments were performed in 30-week-old <i>Ppara</i><sup>HepKO</sup> and littermate control mice fed regular chow. We observed decreased cardiomyocyte contractility (0.17 ± 0.02 vs. 0.24 ± 0.02 μm, <i>p</i> < 0.05), increased cardiac triglyceride content (0.96 ± 0.13 vs. 0.68 ± 0.06 mM, <i>p</i> < 0.05), collagen type 1 (4.65 ± 0.25 vs. 0.31 ± 0.01 AU, <i>p</i> < 0.001), and collagen type 3 deposition (1.32 ± 0.46 vs. 0.05 ± 0.03 AU, <i>p</i> < 0.05). These changes were associated with increased apoptosis as indicated by terminal deoxynucleotidyl transferase dUTP nick end labeling staining (30.9 ± 4.7 vs. 13.1 ± 0.8%, <i>p</i> < 0.006) and western blots showing increased cleaved caspase-3 (0.27 ± 0.006 vs. 0.08 ± 0.01 AU, <i>p</i> < 0.003) and pro-caspase-3 (5.4 ± 1.5 vs. 0.5 ± 0.3 AU, <i>p</i> < 0.02), B-cell lymphoma protein 2-associated X (0.68 ± 0.07 vs. 0.04 ± 0.04 AU, <i>p</i> < 0.001), and reduced B-cell lymphoma protein 2 (0.29 ± 0.01 vs. 1.47 ± 0.54 AU, <i>p</i> < 0.05). We further observed elevated circulating natriuretic peptides and exercise intolerance in <i>Ppara</i><sup>HepKO</sup> mice when compared to controls. Our data demonstrated that lipotoxicity, and fibrosis underlie cardiac dysfunction in MASLD.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":"6 5","pages":"131-142"},"PeriodicalIF":2.7,"publicationDate":"2024-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1096/fba.2023-00139","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140372197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Loren E. Wold, Crislyn D'Souza-Schorey, Yung Hou Wong
<p>In 2019, The Federation of American Societies for Experimental Biology (FASEB) started publishing <i>FASEB BioAdvances</i> as a fully open-access partner to its flagship <i>FASEB Journal</i> for authors to publish their quality research spanning the breadth of the biological and biomedical sciences. Today, the journal publishes a variety of manuscript types, including original research, reviews, and perspectives on current issues in science and academia. The scope of <i>FASEB BioAdvances</i> overlaps with <i>The FASEB Journal</i>, and although its priority is also quality science, it puts less emphasis on perceived impact (e.g., is a sound science journal) and now also welcomes manuscript types that we believe will improve rigor and reproducibility, including replication studies or reports on negative (null) findings.</p><p>Drs. Crislyn D'Souza-Schorey and Yung Hou Wong have served as Editors-in-Chief since January 2022. During their tenure, they have focused their efforts on timely review and publication of cutting-edge science, cross-disciplinary science, and original research. Their efforts have repositioned the journal with a focus that serves it well into the future.</p><p>Recently, FASEB considered how to best grow published output in <i>FASEB BioAdvances</i> without reducing quality or compromising on scientific integrity. FASEB's analysis also identified a need for a seamless process for authors transferring manuscripts from <i>The FASEB Journal</i> to <i>FASEB BioAdvances</i> in a way that further strengthens their partnership. In an effort to increase the value of <i>FASEB BioAdvances</i> to its authors, to decrease the time to first decision, and to better align with the needs of the global author community served by FASEB, we are announcing a change in the editorial structure of the journal. Since February 2024, <i>FASEB BioAdvances</i> is under the direction of Loren E. Wold, PhD, Editor-in-Chief of <i>The FASEB Journal</i> who will work to strengthen both journals. Dr. Wold and team are working on enhancing manuscript transfer options for authors, adding a new dedicated Referral Editor to work between both journals to be a resource for authors, and a plan to introduce greater emphasis on the publication of thematic special collections in areas of considerable importance. <i>The FASEB Journal</i> is fortunate to already have in place a team of over 200 dedicated and diverse researchers: a Senior Editor, a team of eight Associate Editors, and a Special Issues and Reviews Editor, an almost 100-member editorial board, and a 116-member early career researcher editorial board. The <i>FASEB BioAdvances</i> Deputy Editor will continue to serve in that role and will join <i>The FASEB Journal</i> editorial team. Associate Editors of <i>FASEB BioAdvances</i> will continue to serve in their roles. Leveraging this new, broad, and expanded editorial team for both journals will be an important advantage for authors by ensuring rapid review, edi
{"title":"FASEB BioAdvances announces changes in 2024","authors":"Loren E. Wold, Crislyn D'Souza-Schorey, Yung Hou Wong","doi":"10.1096/fba.2024-00043","DOIUrl":"10.1096/fba.2024-00043","url":null,"abstract":"<p>In 2019, The Federation of American Societies for Experimental Biology (FASEB) started publishing <i>FASEB BioAdvances</i> as a fully open-access partner to its flagship <i>FASEB Journal</i> for authors to publish their quality research spanning the breadth of the biological and biomedical sciences. Today, the journal publishes a variety of manuscript types, including original research, reviews, and perspectives on current issues in science and academia. The scope of <i>FASEB BioAdvances</i> overlaps with <i>The FASEB Journal</i>, and although its priority is also quality science, it puts less emphasis on perceived impact (e.g., is a sound science journal) and now also welcomes manuscript types that we believe will improve rigor and reproducibility, including replication studies or reports on negative (null) findings.</p><p>Drs. Crislyn D'Souza-Schorey and Yung Hou Wong have served as Editors-in-Chief since January 2022. During their tenure, they have focused their efforts on timely review and publication of cutting-edge science, cross-disciplinary science, and original research. Their efforts have repositioned the journal with a focus that serves it well into the future.</p><p>Recently, FASEB considered how to best grow published output in <i>FASEB BioAdvances</i> without reducing quality or compromising on scientific integrity. FASEB's analysis also identified a need for a seamless process for authors transferring manuscripts from <i>The FASEB Journal</i> to <i>FASEB BioAdvances</i> in a way that further strengthens their partnership. In an effort to increase the value of <i>FASEB BioAdvances</i> to its authors, to decrease the time to first decision, and to better align with the needs of the global author community served by FASEB, we are announcing a change in the editorial structure of the journal. Since February 2024, <i>FASEB BioAdvances</i> is under the direction of Loren E. Wold, PhD, Editor-in-Chief of <i>The FASEB Journal</i> who will work to strengthen both journals. Dr. Wold and team are working on enhancing manuscript transfer options for authors, adding a new dedicated Referral Editor to work between both journals to be a resource for authors, and a plan to introduce greater emphasis on the publication of thematic special collections in areas of considerable importance. <i>The FASEB Journal</i> is fortunate to already have in place a team of over 200 dedicated and diverse researchers: a Senior Editor, a team of eight Associate Editors, and a Special Issues and Reviews Editor, an almost 100-member editorial board, and a 116-member early career researcher editorial board. The <i>FASEB BioAdvances</i> Deputy Editor will continue to serve in that role and will join <i>The FASEB Journal</i> editorial team. Associate Editors of <i>FASEB BioAdvances</i> will continue to serve in their roles. Leveraging this new, broad, and expanded editorial team for both journals will be an important advantage for authors by ensuring rapid review, edi","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":"6 4","pages":"103-104"},"PeriodicalIF":2.7,"publicationDate":"2024-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1096/fba.2024-00043","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140227217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}